Skip to main content
Log in

Should liver transplantation be performed before advanced renal insufficiency in primary hyperoxaluria type 1?

  • Practical Pediatric Nephrology
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Primary hyperoxaluria type 1 (PH1) is a rare recessive autosomal inborn error of glyoxylate metabolism leading to oxalate retention, the first target of which is the kidney. The disease is caused by a defect of the liver-specific peroxisomal enzyme alanine: glyoxylate aminotransferase. Patients with pyridoxine-resistant forms of PH1 usually require organ replacement therapy, i.e. liver transplantation to supply the deficient enzyme and/or kidney transplantation to replace the affected organ. The current experience of the management of Ph1 has emphasized two main points: (1) end-stage renal failure must be avoided since it increases dramatically the risk of systemic involvement, (2) the correction of oxalate overproduction and organ overload requires the removal of the host liver. Practical attitudes towards these ideas are difficult to assess and an individualized strategy is therefore required. Isolated kidney transplantation should be limited to adult patients with late-onset and a mild course of the disease. The present experience of combined liver-kidney transplantation was gained mainly in adult patients with severe systemic involvement; the 3-year patient survival rate recently increased to 82%. This figure might be improved if the procedure were performed earlier while the glomerular filtration rate (GFR) is above 25 ml/min per 1.73 m2. Isolated liver transplantation should be considered in carefully selected children with severe forms of pyridoxineresistance (PH1) before GFR has dropped to less than 30 ml/min per 1.73 m2; it seems to be indicated especially in the presence of a rapid decline of GFR in the preceding year. In two young children who underwent isolated liver transplantation in our units 4 years ago, renal function could be stabilized and severe extrarenal involvement prevented.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Danpure CJ (1991) Molecular and clinical heterogeneity in primary hyperoxaluria type 1. Am J Kidney Dis 17:366–369

    Google Scholar 

  2. Danpure CJ, Jennings PR (1986) Peroxisomal alanine: glyoxylate aminotransferase deficiency in primary hyperoxaluria type I. FEBS Lett 201:20–24

    Google Scholar 

  3. Danpure CJ (1991) Scientific rationale for hepato-renal transplantation in primary hyperoxaluria type 1. Transplant Clin Immunol 22:91–98

    Google Scholar 

  4. Latta K, Brodehl J (1990) Primary hyperoxaluria type I. Eur J Pediatr 149:518–522

    Google Scholar 

  5. Watts RWE, Mansell MA (1990) Oxalate, livers, and kidneys. Combined renal and hepatic transplants transform the outlook in primary hyperoxaluria type I. B M J 301:772–773

    Google Scholar 

  6. Scheinman JI, Najarian JS, Mauer SM (1984) Successful strategies for renal transplantation in primary oxalosis. Kidney Int 25:804–811

    Google Scholar 

  7. Leumann EP, Niederwieser A, Fanconi A (1987) New aspects of infantile oxalosis. Pediatr Nephrol 1:531–535

    Google Scholar 

  8. Morgan SH, Purkiss P, Watts RWE, Mansell MA (1987) Oxalate dynamics in chronic renal failure. Comparison with normal subjects and patients with primary hyperoxaluria. Nephron 46:253–257

    Google Scholar 

  9. Watts RWE, Danpure CJ, De Pauw L, Toussaint C and the European Study Group on Transplantation in Hyperoxaluria Type 1 (1991) Combined liver-kidney and isolated liver-transplantation for primary hyperoxaluria type 1: the European experience. Nephrol Dial Transplant 6:502–511

    Google Scholar 

  10. Lloveras JJ, Dupré-Goudable C, Rey JP, Sporer P, Durand D, Ton That H, Suc JM (1991) Experience européenne de transplantation hépato-rénale dans l'hyperoxalurie primitive de type 1. Prévention de la récidive des dépots d'oxalate au niveau du rein. Presse Med 20:2016–2018

    Google Scholar 

  11. Deodhar SD, Tung KSK, Zühlke V, Nakamoto S (1969) Renal homotransplantation in a patient with primary familial oxalosis. Arch Pathol 87:118–124

    Google Scholar 

  12. Watts RWE, Calne RY, Rolles K, Danpure CJ, Morgan SH, Mansell MA, Williams R, Purkiss P (1987) Successful treatment of primary hyperoxaluria type 1 by combined hepatic and renal transplantation. Lancet II:474–475

    Google Scholar 

  13. Watts RWE, Morgan SH, Purkiss P, Mansell MA, Baker LRI, Brown CB (1988) Timing of renal transplantation in the management of pyridoxine-resistant type 1 primary hyperoxaluria. Transplantation 45:1143–1145

    Google Scholar 

  14. Katz A, Mauer SM (1992) Transplantation in primary hyperoxaluria type 1. Am J Med 92:341–342

    Google Scholar 

  15. Broyer M, Brunner FP, Brynger H, Dykes SR, Ehrich HH, Fassbinder W, Geerlings W, Rizzoni G, Selwood NH, Tufveson G, Wing AJ (1990). Kidney transplantation in primary oxalosis: data from the EDTA registry. Nephrol Dial Transplant 5:332–336

    Google Scholar 

  16. Watts RWE, Morgan SH, Danpure CJ, Purkiss P, Calne RY, Rolles K, Baker LRI, Mansell MA, Smith LH, Merion RM, Lucey MR (1991) Combined hepatic and renal transplantation in primary hyperoxaluria type 1: clinical report of 9 cases. Am J Med 90:179–188

    Google Scholar 

  17. Katz A, Kim Y, Scheinman JI, Najarian JS, Mauer SM (1989) Long-term outcome of kidney transplantation in children with oxalosis. Transplant Proc 21:2033–2035

    Google Scholar 

  18. Friedmann T (1991) Approaches to human gene therapy. In: Schaub J, Van Hoof F, Vis HL (eds) Inborn errors of metabolism. Nestlé Nutrition Workshop Series, vol. 24. Raven, New York, pp 275–282

    Google Scholar 

  19. Cochat P, Guibaud P (1991) Principles of organ transplantation in inborn errors of metabolism. Transplant Clin Immunol 22:73–82

    Google Scholar 

  20. Malatack JJ, Finegold DN, Iwatsuki S, Shaw BW, Gartner JC, Zitelli BJ, Roe T, Starzl TE (1983) Liver transplantation for type 1 glycogen storage diseases. Lancet I:1073–1075

    Google Scholar 

  21. Bilheimer DW, Goldstein JL, Grundy SM, Starzl TE, Brown MS (1984) Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia. N Engl J Med 311:1658–1664

    Google Scholar 

  22. Terpstra OT, Reuvers CB, Schlam SW (1989) Auxiliary heterotopic liver transplantation. Transplantation 45:1003–1007

    Google Scholar 

  23. Gordon RD, Todo S, Tzakis AG, Fung JJ, Stieber A, Staschak SM, Iwatsuki S, Starzl TE (1991) Liver transplantation under cyclosporine: a decade of experience. Transplant Proc 23:1393–1396

    Google Scholar 

  24. Cohen AT, Mowat AP, Bhaduri BH, Noble-Jamieson G, Williams R. Barnes, Calne RY (1991) Liver transplantation for inborn errors of metabolism and genetic disorders. In: Schaub J, Van Hoof F, Vis HL (eds) Inborn errors of metabolism; Nestlé Nutrition Workshop Series, vol. 24. Raven, New York, pp 213–222

    Google Scholar 

  25. Bismuth H, Castaing D, Ericzon BG, Otte JB, Ringer B, Rolles K, Sloff MJH (1991) European liver transplant registry: updating 30.06.91. Sandoz (ed), Paris

  26. Gonwa TA, Morris CA, Goldstein RM, Husberg BS, Klintmalm GB (1991) Long term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome. Experience in 300 patients. Transplantation 51:428–430

    Google Scholar 

  27. Watts RWE, Calne RY, Williams R, Mansell MA, Veall N, Purkiss P, Rolles K (1985) Primary hyperoxaluria (type 1): attempted treatment by combined hepatic and renal transplantation. Q J Med 57:697–703

    Google Scholar 

  28. Jamieson NV, Watts RWE, Evans DB, Williams R, Calne RY (1991) Liver and kidney transplantation in the treatment of primary hyperoxaluria. Transplant Proc 23:1557–1558

    Google Scholar 

  29. Polinski MS, Dunn S, Kaiser BA, Schulman SL, Wolfson BJ, Elfenhein IB, Baluarte HJ (1991) Combined liver-kidney transplantation in a child with primary hyperoxaluria. Pediatr Nephrol 5:332–334

    Google Scholar 

  30. Jouvet P, Hubert P, Jan D, Niaudet P, Beringer A, Narcy C, Daudon M, Broyer M, Révillon Y (1991) Transplantation hépatique et rénale dans le traitement de l'hyperoxalurie de type I. Arch Fr Pediatr 48:637–639

    Google Scholar 

  31. Ruder H, Otto G, Schutgens RBM, et al. (1991) Excessive urinary oxalate excretion after combined renal and hepatic transplantation for correction of hyperoxaluria type 1. Eur J Pediatr 150:56–58

    Google Scholar 

  32. De Pauw L, Gelin M, Danpure CJ, Vereerstraeten P, Adler M, Abramowicz D, Toussaint C (1990) Combined liver-kidney transplantation in primary hyperoxaluria type 1. Transplantation 50:866–887

    Google Scholar 

  33. Rodby RA, Tyszka TS, Williams JW (1991) Reversal of cardiac dysfunction secondary to type 1 primary hyperoxaluria after combined liver-kidney transplantation. Am J Med 90:468–504

    Google Scholar 

  34. Cuervas-Mons V (1986) An analysis of the early causes of death in 40 consecutive cases. Hepatology 6:495–501

    Google Scholar 

  35. McDiarmid SV, Ettenger RB, Fine RN, Busutill RW, Ament ME (1989) Serial decrease in glomerular filtration rate in long-term pediatric liver transplantation survivors treated with cyclosporine. Transplantation 47:314–318

    Google Scholar 

  36. Andrews WA, Arant BS, Byock B, Gray S, Schlatter MG, Coulin C (1991) The effect of cyclosporine A on long-term renal function in pediatric liver recipients. Transplant Proc 23:1452–1453

    Google Scholar 

  37. McDonald JC, Landreneau MD, Rohr MS, De Vault GA Jr (1989) Reversal by liver transplantation of the complications of primary hyperoxaluria as well as the metabolic defect. N Engl J Med 321:1100–1103

    Google Scholar 

  38. Porayko MK, Wiesner RH, Hay JE, Krom RAF, Dickson ER, Beaver S, Schwerman L (1991) Bone disease in liver transplant recipients: incidence, timing, and risk factors. Transplant Proc 23:1462–1465

    Google Scholar 

  39. Cochat P, Faure JL, Divry P, Danpure CJ, Descos B, Wright C, Takvorian P, Floret D (1989) Liver transplantation in primary hyperoxaluria type 1. Lancet I:1142–1143

    Google Scholar 

  40. Schürmann G, Schärer K, Wingen AM, Otto G, Herfarth C (1990) Early liver transplantation for primary hyperoxaluria type 1 in an infant with chronic renal failure. Nephrol Dial Transplant 5:825–827

    Google Scholar 

  41. Watts RWE (1990) Treatment of renal failure in the primary hyperoxalurias. Nephron 56:1–5

    Google Scholar 

  42. Scheinman JI (1991) Primary hyperoxaluria: therapeutic strategies for the 90's. Kidney Int 40:389–399

    Google Scholar 

  43. Ellis D, Avner ED, Starzl TE (1986) Renal failure in children with hepatic failure undergoing liver transplantation. J pediatr 108:393–398

    Google Scholar 

  44. Bonsel GJ, Essink-Bot ML, Klompmaker IJ, Sloof MJH (1992) Assessment of the quality of life before and following liver transplantation. Transplantation 53:796–800

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cochat, P., Schärer, K. Should liver transplantation be performed before advanced renal insufficiency in primary hyperoxaluria type 1?. Pediatr Nephrol 7, 212–218 (1993). https://doi.org/10.1007/BF00864408

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00864408

Key words

Navigation